Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Dissecting the actions of widely used diabetes drugs.

Unger RH, Berglund ED, Habener JF, Cherrington AD.

Nat Med. 2013 Mar;19(3):272-3. doi: 10.1038/nm.3123. No abstract available.

PMID:
23467236
2.

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.

Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ.

Nature. 2013 Feb 14;494(7436):256-60. doi: 10.1038/nature11808. Epub 2013 Jan 6.

3.

Diabetic hearts and biguanides.

Biron P.

Can Med Assoc J. 1975 Aug 9;113(3):175-6. No abstract available.

4.

[Differences between 2 antidiabetic biguanides: metformin and phenformin].

[No authors listed]

Journ Annu Diabetol Hotel Dieu. 1972;13(0):332-9. Review. French. No abstract available.

PMID:
4605621
5.

[What is the role of the biguanides in the treatment of diabetes mellitus?].

Hazard J.

Sem Hop. 1978 Feb;54(4):220-3. French. No abstract available.

PMID:
208172
6.

The treatment of diabetes mellitus with oral hypoglycaemic drugs.

Duncan LJ, Clarke BF, Munro JF.

Curr Med Drugs. 1965 Jun;5(10):23-32. No abstract available.

PMID:
5878054
7.

[Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].

Cabezas Cerrato J, Fernández-Cruz A Jr, Fernández-Cruz A.

Rev Clin Esp. 1970 May 31;117(4):375-86. Spanish. No abstract available.

PMID:
5471527
8.

Comparison of gene expression changes induced by biguanides in db/db mice liver.

Heishi M, Hayashi K, Ichihara J, Ishikawa H, Kawamura T, Kanaoka M, Taiji M, Kimura T.

J Toxicol Sci. 2008 Aug;33(3):339-47.

9.

A differential action of phenformin in normal and diabetic rat livers.

Connon JJ.

Diabetologia. 1973 Feb;9(1):47-9. No abstract available.

PMID:
4267107
10.

[Effect of biguanide derivatives on blood lactic acid level in diabetics].

Lao B, Okniński W.

Pol Arch Med Wewn. 1971 Dec;47(6):675-8. Polish. No abstract available.

PMID:
5139041
11.

Oral treatment of diabetes mellitus.

Chhetri MK.

J Indian Med Assoc. 1968 May 16;50(10):486-8. Review. No abstract available.

PMID:
4883853
12.

Biguanides.

Nattrass M, Alberti KG.

Diabetologia. 1978 Feb;14(2):71-4. No abstract available.

PMID:
631459
13.

Metformin and insulin meet in a most atypical way.

White MF.

Cell Metab. 2009 Jun;9(6):485-7. doi: 10.1016/j.cmet.2009.05.007.

15.

Studies on the effect of oral hypoglycaemic agents on hepatic glycogenolysis.

Saleh S, Abdel-Khalek A, Khayyal MT, Masri AM, Sharat AA.

Pharmacol Res Commun. 1974 Dec;6(6):539-50. No abstract available.

PMID:
4376601
16.

The target of metformin in type 2 diabetes.

Ferrannini E.

N Engl J Med. 2014 Oct 16;371(16):1547-8. doi: 10.1056/NEJMcibr1409796. No abstract available.

PMID:
25317875
17.

Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.

Nattrass M, Todd PG, Hinks L, Lloyd B, Alberti KG.

Diabetologia. 1977 Apr;13(2):145-52.

PMID:
404205
18.

[Pharmacokinetics of blood glucose lowering biguanide derivatives].

Mehnert H.

Acta Diabetol Lat. 1969 Sep;6 Suppl 1:137-42. Review. Multiple languages. No abstract available.

PMID:
4906018
19.

Metformin and the intestine.

Bailey CJ, Wilcock C, Scarpello JH.

Diabetologia. 2008 Aug;51(8):1552-3. doi: 10.1007/s00125-008-1053-5. Epub 2008 Jun 5. No abstract available.

PMID:
18528677
20.

[On the clinical use of biguanides].

Haese E.

Arzneimittelforschung. 1969 Apr;19(4):633-8. German. No abstract available.

PMID:
5819164
Items per page

Supplemental Content

Write to the Help Desk